The Challenges of Reproductive Autonomy in an Unjust System.
Megan A Allyse, Shivangi Sengupta, Marsha Michie
https://pubmed.ncbi.nlm.nih.gov/41252505/Actively Recruiting
Led by Case Western Reserve University · Updated on 2026-09-22
1400
Participants Needed
3
Research Sites
N/A
Total Duration
This research aims to evaluate a mobile-based educational tool designed to support pregnant participants in making informed decisions about prenatal genetic screening. The study compares people who use this intervention before their first prenatal doctors visit to those who receive usual care without the tool. The main question is whether participants who use the intervention feel more confident about their screening decisions. Participants in the intervention group will access the educational tool on their mobile phone via a QR code before their clinical visit. They will complete a short online survey right after using the tool and participate in a phone interview within seven days after seeing their doctor to assess their experience and decision confidence. Some participants in this group may have an additional interview to explore the tools effectiveness and usability. Those in the standard care group will receive usual information and counseling and complete a similar phone interview after their doctors visit. During the study, all participants will be engaged through phone interviews and surveys to measure their decisional self-efficacy up to seven days post-visit. Researchers will collect information on how the intervention influences confidence in decision-making about prenatal screening. The study is sponsored by Case Western Reserve University and includes pregnant participants receiving care at select clinical sites. Participation involves using the intervention, completing surveys, and phone interviews over a short period around the initial prenatal visit.
CONDITIONS
Supporting Just-In-Time Consent for Prenatal Screening: The INFORM Study
S
Sabina Rubeck, MPH
H
Harlie Custer, MA, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Case Western Reserve University
Lead Sponsor
National Human Genome Research Institute (NHGRI)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Mobile educational tool | Standard care without tool | Standard guideline counseling |
|---|---|---|---|
| What it is | A QR‑code accessed mobile educational tool that briefly provides clear prenatal genetic screening information before the clinical visit. | Usual prenatal care without the mobile educational tool. | Routine pretest counseling based on professional society guidance for prenatal genetic screening. |
| What is studied | Provides concise information via mobile tool to support informed decision‑making before screening. | Standard visit discussions without additional educational tool. | Professional society–recommended pretest counseling to inform patients of risks, benefits, and options. |
| How it is given or performed | Accessed via QR code on mobile device before provider visit, followed by phone survey. | Usual consent process during prenatal visit without prior educational tool. | Counseling delivered by provider during prenatal visit according to guideline standards. |
| Evidence on decision‑making support | Under investigation; this trial is assessing whether the tool increases decision self‑efficacy. | Baseline for current trial; evidence of decision‑making support is not established by this study. | Established counseling approaches recommended to support informed decision‑making though impact varies. |
| Limitations | Effect depends on access to mobile device, literacy level, and may vary across patients. | Relies on in‑visit discussion which may be brief or variable across providers. | Counseling time, provider variation, and information overload can limit effectiveness. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - One day (around the first prenatal visit)
Participants either use the mobile educational tool before their first prenatal doctor's visit or receive usual care without the tool. All participants then attend their prenatal visit as usual.
Duration - Up to 7 days after the prenatal visit
Participants complete phone interviews and surveys within seven days after their prenatal visit to measure decision confidence and experience with prenatal screening.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Megan A Allyse, Shivangi Sengupta, Marsha Michie
https://pubmed.ncbi.nlm.nih.gov/41252505/Megan Allyse, Kirsten Riggan, Natasha Bonhomme...
https://pubmed.ncbi.nlm.nih.gov/40245273/Case Western Reserve University
Lead Sponsor
National Human Genome Research Institute (NHGRI)
Collaborating Sponsor